Rigel Reports First Quarter 2026 Financial Results

Go back to Rigel Reports First Quarter 2026 Financial Results
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 36.21 +0.48 (1.34%)
Previous Close $35.73    52 Week High $4.38 
Open $35.85    52 Week Low $1.88 
Day High $36.36    P/E N/A 
Day Low $35.70    EPS $-1.12 
Volume 51,876